Celerion · 2 weeks ago
Pharmacokinetic Scientist
United States+1 more
Full-time
Remote
Mid Level
2+ years expCelerion is committed to swift, exceptional clinical research through translational medicine. We are looking for a full-time Pharmacokinetic Scientist to join our Clinical Pharmacology team, responsible for pharmacokinetic data analysis, scientific interpretation of study results, clinical report writing, and client interactions.
HealthcarePharmaceuticalHealth Care
Responsibilities
Data analysis and interpretation
Perform PK analyses independently
Assist with PD analyses
Interpret PK and statistical results and findings independently
Perform QC reviews as assigned
Write and review reports as assigned
Prepare PK data/report files for electronic filing of projects for submission to regulatory agencies
Maintain and file all supportive documentation pertaining to the study and ensure proper archiving of projects
Other responsibilities
Interact with clients alongside or under direction of a senior scientist, as needed
Prepare internal presentations
Qualification
Required
Master's or PhD degree in a biology-focused sciences related field with 2+ years of related experience required
Competence in performing noncompartmental pharmacokinetic analysis with software applications such as Phoenix WinNonlin
Excellent oral and written skills (English language) required
Preferred
Familiarity with processes and applications related to non-linear mixed-effect modeling and/or physiologically-based pharmacokinetic modeling is an asset
Company
Celerion
Celerion, a leader in early clinical research, delivers Applied Translational Medicine.
1001-5000 employees
H1B Sponsorship
Celerion has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
94%
Represents job field similar to this job
Engineering and Development
Management and Executive
Trends of Total Sponsorships
*2026 (1)
2025 (5)
2024 (7)
2023 (5)
2022 (3)
2021 (6)
2020 (5)
Funding
Current Stage
Late StageTotal Funding
unknown2026-03-22Acquired
2010-01-01Seed
Leadership Team
Susan C. Thornton
President and CEO
JoAnne Rosal
Chief Financial Officer
Recent News
2026-07-03
Private Equity Wire
2026-06-17
Company data provided by crunchbase